Eikon Therapeutics, Inc. Common Stock (EIKN) vs Senseonics Holdings, Inc. (SENS)

A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$415M
$7.67HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Senseonics Holdings, Inc. logo
SENS
Senseonics Holdings, Inc.
$415M
$9.92HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT

Total return — EIKN vs SENS

growth of $100 · dividends reinvested · last 1y
EIKN -49.7% (-49.7%/yr)SENS +49.2% (+49.2%/yr)SENS compounded faster over this window
6080100120140Start $100$50$149
EIKN SENS

EIKN vs SENS: by the numbers

  • •EIKN is the larger company ($415M vs $415M market cap).
  • •Both run net losses; EIKN's is the smaller (0.00% vs -225.34% net margin).

Metrics side by side

Valuation

MetricEIKNSENS
P/S ratioN/A8.54
P/B ratio0.894.59

Profitability

MetricEIKNSENS
Gross margin0.00%44.71%
Operating margin0.00%-193.83%
Net margin0.00%-225.34%
ROE-69.06%-121.12%
ROIC-46.16%-71.22%

Growth (annualized)

MetricEIKNSENS
Revenue CAGR (5Y)N/A35.10%
Total return CAGR (5Y)N/A-30.89%

Go deeper

Full EIKN analysisFull SENS analysisInteractive comparison tool

Dig into the metrics

Eikon Therapeutics, Inc. Common Stock ROESenseonics ROEEikon Therapeutics, Inc. Common Stock operating marginSenseonics operating marginEikon Therapeutics, Inc. Common Stock revenue growthSenseonics revenue growthEikon Therapeutics, Inc. Common Stock free cash flowSenseonics free cash flow

Eikon Therapeutics, Inc. Common Stock & Senseonics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.